Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-03

Clinical Trial Update: Cefazolin Subcutaneous Microdialysis in Morbidly Obese Patients

View source ↗

Summary

A clinical trial evaluated Cefazolin delivered via subcutaneous microdialysis in morbidly obese patients to study pharmacokinetics. The study status is reported…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Morbid Obesity | Status: COMPLETED